In summary, our study found the up-expression of ANRIL in ovarian cancer tissues and drug-resistant cells, and silencing ANRIL could increase let-7a to further reduce HMGA2, which can promote the apoptosis and improve the cisplatin sensitivity of ovarian cancer cells. This evidence concerns the gene HMGA2 and ovarian cancer.